Victoria P Werth Selected Research

Cytokines

3/2024	International exchange on the clinical practice and research of rheumatic skin diseases: A report of the 5th International Conference of Cutaneous Lupus Erythematosus.
1/2024	Extracellular Vesicles in the Pathogenesis, Clinical Characterization, and Management of Dermatomyositis: A Narrative Review.
12/2023	Neutrophil extracellular traps drive lupus flares with acute skin and kidney inflammation triggered by ultraviolet irradiation.
11/2023	Herbal supplement Spirulina stimulates inflammatory cytokine production in patients with dermatomyositis in vitro.
1/2022	Rho Kinase regulates neutrophil NET formation that is involved in UVB-induced skin inflammation.
1/2021	Plasma-derived DNA containing-extracellular vesicles induce STING-mediated proinflammatory responses in dermatomyositis.
1/2019	Increased Myeloid Dendritic Cells and TNF-α Expression Predicts Poor Response to Hydroxychloroquine in Cutaneous Lupus Erythematosus.
1/2019	Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.
11/2017	Cannabinoid Reduces Inflammatory Cytokines, Tumor Necrosis Factor-α, and Type I Interferons in Dermatomyositis In Vitro.
11/2016	Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria P Werth Research Topics

Disease

43	Dermatomyositis (Dermatopolymyositis) 12/2024 - 09/2002
35	Cutaneous Lupus Erythematosus 12/2024 - 09/2002
22	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2024 - 04/2011
17	Skin Diseases (Skin Disease) 12/2024 - 12/2002
15	Pemphigus (Pemphigus Vulgaris) 03/2024 - 06/2005
9	Inflammation (Inflammations) 03/2024 - 03/2012
8	Autoimmune Diseases (Autoimmune Disease) 03/2024 - 09/2002
7	Infections 01/2023 - 07/2008
6	Bullous Pemphigoid (Pemphigoid) 03/2024 - 09/2002
6	Neoplasms (Cancer) 12/2023 - 02/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 12/2007
5	Localized Scleroderma (Morphea) 04/2021 - 12/2009
5	Osteoporosis 04/2021 - 01/2006
5	Myositis (Idiopathic Inflammatory Myopathies) 02/2021 - 01/2006
4	Dermatitis 03/2021 - 09/2002
3	Bites and Stings (Sting) 01/2024 - 01/2021
3	Exanthema (Rash) 01/2023 - 01/2006
3	Rupture 01/2022 - 01/2020
3	Skin Manifestations 03/2021 - 10/2007
3	Arthritis (Polyarthritis) 01/2018 - 07/2010
3	Discoid Lupus Erythematosus 01/2017 - 03/2009
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2022
2	Neutropenia 01/2022 - 03/2009
2	Rheumatoid Arthritis 12/2021 - 04/2017
2	Body Weight (Weight, Body) 09/2021 - 01/2021
2	Human Influenza (Influenza) 03/2021 - 01/2017
2	Hepatitis 03/2021 - 02/2017
2	Lupus Nephritis 10/2018 - 08/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018 - 10/2016
2	Vasculitis (Vasculitides) 01/2018 - 07/2010
2	Carcinoma (Carcinomatosis) 01/2018 - 09/2015
2	Herpes Zoster 01/2017 - 11/2016
2	Sarcoidosis (Schaumann Disease) 12/2015 - 05/2013
2	Bone Resorption 12/2007 - 06/2006
2	Erythema Nodosum 07/2007 - 01/2003
2	Congenital Abnormalities (Deformity) 07/2007 - 01/2003
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2024
1	Breast Neoplasms (Breast Cancer) 12/2024

Drug/Important Bio-Agent (IBA)

17	Antimalarials (Antimalarial Agents)IBA 10/2022 - 07/2005
11	AutoantibodiesIBA 12/2023 - 09/2002
10	CytokinesIBA 03/2024 - 11/2016
9	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 09/2002
9	InterferonsIBA 02/2024 - 09/2013
9	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2022 - 04/2017
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 09/2002
8	GlucocorticoidsIBA 01/2021 - 06/2005
7	Monoclonal AntibodiesIBA 05/2023 - 10/2013
7	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2023 - 01/2006
7	Quinacrine (Mepacrine)IBA 04/2021 - 01/2017
7	Rituximab (Mabthera)FDA Link 01/2021 - 04/2011
6	Interferon Type IIBA 02/2024 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2002
6	Intravenous Immunoglobulins (IVIG)FDA Link 10/2023 - 08/2003
6	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2006
5	Immunosuppressive Agents (Immunosuppressants)IBA 07/2022 - 06/2005
5	SteroidsIBA 02/2011 - 06/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2012
4	AntibodiesIBA 12/2021 - 08/2012
4	Immunoglobulin A (IgA)IBA 12/2021 - 09/2015
4	MucinsIBA 01/2018 - 05/2007
3	Immunoglobulin G (IgG)IBA 02/2024 - 12/2021
3	lenabasum (ajulemic acid)IBA 12/2023 - 01/2022
3	AntigensIBA 05/2023 - 12/2002
3	Dapsone FDA Link 10/2022 - 06/2005
3	Prednisone (Sone)FDA LinkGeneric 07/2022 - 06/2005
3	iberdomideIBA 04/2022 - 01/2022
3	CannabinoidsIBA 03/2022 - 11/2017
3	ChromatinIBA 01/2022 - 09/2002
3	Antinuclear AntibodiesIBA 11/2019 - 08/2012
3	Chondroitin Sulfates (Chondroitin Sulfate)IBA 07/2012 - 03/2011
3	Thalidomide (Thalomid)FDA Link 04/2012 - 01/2003
3	CollagenIBA 02/2011 - 05/2007
3	Diphosphonates (Bisphosphonates)IBA 12/2007 - 01/2006
2	InterleukinsIBA 03/2024 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2011
2	Lamin Type B (Lamin B)IBA 01/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Environmental Pollutants (Pollutants, Environmental)IBA 03/2021 - 01/2019
2	Interleukin-12 (IL 12)IBA 10/2018 - 01/2003
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 09/2015
2	anifrolumabIBA 01/2018 - 01/2017
2	Prostaglandins AIBA 12/2015 - 05/2013
2	Matrix Metalloproteinases (MMPs)IBA 10/2013 - 02/2003
2	Lenalidomide (CC 5013)FDA Link 04/2012 - 03/2009
2	Hyaluronic Acid (Hyaluronan)IBA 08/2011 - 03/2011
2	Carbon MonoxideIBA 10/2010 - 07/2010
1	Antiphospholipid AntibodiesIBA 12/2024
1	Hormones (Hormone)IBA 12/2024
1	Contraceptive Agents (Contraceptives)IBA 12/2024
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024
1	Interleukin-13IBA 03/2024
1	dupilumabIBA 03/2024
1	pyromellitic acid dianhydride-2-hydroxyethyl methacrylate adductIBA 02/2024
1	RSLV-132IBA 02/2024

Therapy/Procedure

33	Therapeutics 03/2024 - 07/2005
2	Lasers (Laser) 01/2023 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2018 - 12/2006
2	Chemoprevention 01/2018 - 09/2015
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 12/2024